#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Adrenoleukodystrophy Myxofibrosarcoma Malignant oligodendroglioma Paroxysmal nocturnal haemoglobinuria Bronchiectasis Epstein-Barr virus infection Graft versus host disease Arrhythmia Synovial sarcoma Hepatoblastoma Nephropathy Non-small cell lung cancer metastatic Myasthenia gravis Becker's muscular dystrophy Activated PI3 kinase delta syndrome More trials…

    Learn about Rare Diseases

    Methylmalonic acidaemia – Diagnostics Mantle cell lymphoma stage III – Treatment Toxic epidermal necrolysis – Diagnostics Myelodysplastic syndrome – Basic Information Von Willebrand’s disease – Diagnostics Hereditary ataxia – Trials in Disease Von Willebrand’s disease – Trials in Disease Von Willebrand’s disease – Basic Information Pulmonary fibrosis Mantle cell lymphoma stage II – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Bleomycin Sulfate Cd19-Car_Lenti_Allo Ruxotemitide Ketamine Hydrochloride Midazolam Omaveloxolone Mps-216 Eo2317 Levocabastine Hydrochloride Iohexol Ubamatamab Intestifix Tamoxifen Ethinylestradiol Alizapride Zinc Acexamate Dordaviprone Domvanalimab Taurine Falbikitug More therapies…

    Learn about Your Condition

    Pulmonary embolism Pelizaeus-Merzbacher disease Periarthritis Angiosarcoma recurrent Vascular calcification Thromboangiitis obliterans Erosive oesophagitis Death neonatal Still's disease Antithrombin III deficiency Diabetes mellitus Underweight White matter lesion Ependymoma malignant Atrial fibrillation More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Safety of flecainide acetate compared with amiodarone hydrochloride and sotalol in patients with atrial fibrillation and stable coronary artery disease

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Coronary artery disease
    • Atrial fibrillation
    Investigated Drugs:
    • Sotalol
    • Amiodarone Hydrochloride
    • Flecainide Acetate
    Belgium

  • Safety, tolerability and exploratory efficacy of PST-611 in patients with geographic atrophy secondary to age-related macular degeneration

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Dry age-related macular degeneration
    • Age-related macular degeneration
    France

  • Evaluation of PIFLUFOLASTAT (18F) PET/CT for monitoring prostate cancer recurrence in patients with favourable intermediate‑risk localized disease after focal HIFU

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Prostate cancer
    France

  • Dose optimization study of ibrutinib drug combination in adult patients with haematological diseases

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Waldenstrom’s macroglobulinaemia
    • Plasma cell myeloma refractory
    Investigated Drugs:
    • Ibrutinib
    • Talquetamab
    • Linvoseltamab
    Denmark

  • Study of inhaled levodopa versus oral levodopa plus benserazide for early‑morning OFF in Parkinson’s disease patients

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Parkinson’s disease
    Investigated Drugs:
    • Benserazide Hydrochloride
    • Levodopa
    Denmark

  • Colchicine after Electrocardioversion to Prevent Recurrence of Atrial Fibrillation in Adult Patients

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Atrial fibrillation
    Investigated Drugs:
    • Colchicine
    Germany
Previous Page
1 … 688 689 690 691 692 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!